Pimicotinib Data Show Durable Tumor Control Through Two Years
Two-year data reported sustained improvement in TGCT symptoms and joint function, including pain, stiffness and range of motion.
Two-year data reported sustained improvement in TGCT symptoms and joint function, including pain, stiffness and range of motion.